Valuation Agenus Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-26 EDT			5-day change	1st Jan Change
8.250 ^USD	-1.32%		-0.12%	+162.74%

08-11	Agenus Inc. Announces Appointment of Marco Tullio Marcucci as Director and as A Member of Corporate Governance and Nominating Committee, Effective August 5, 2026	CI
08-07	Agenus Files for Resale of Up to 78 Million Shares	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	827	731.5	315.8	64.28	106.8	371.4	-	-
Change	-	-11.54%	-56.83%	-79.65%	66.13%	247.81%	-	-
Enterprise Value (EV)	827	731.5	315.8	64.28	106.8	371.4	371.4	371.4
Change	-	-11.54%	-56.83%	-79.65%	66.13%	247.81%	0%	0%
P/E	-29.3x	-3.08x	-1.2x	-0.26x	-	12.1x	-33.7x	-18.8x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	0.1x	0x	-	-	0x	-0.2x
Capitalization / Revenue	2.8x	7.46x	2.02x	0.62x	0.94x	2.65x	2.7x	2.9x
EV / Revenue	0x	0x	0x	0x	0x	2.65x	2.7x	2.9x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	0x	-0x	-0x	-0x	-0x	7.95x	12.9x	-619x
EV / FCF	-0x	-0x	-0x	-0x	-0x	53.1x	-18.8x	-8.35x
FCF Yield	-2.86%	-31.2%	-74.1%	-247%	-72.3%	1.88%	-5.33%	-12%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.2	-15.6	-13.8	-10.59	-	0.68	-0.245	-0.44
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	295.7	98.02	156.3	103.5	114.2	140.3	137.4	128.2
EBITDA	-	-154.1	-	-	-	-	-	-
EBIT ¹	25.75	-179.4	-159.5	-124.4	-20.17	46.7	28.85	-0.6
Net income ¹	-24.14	-230.7	-257.4	-232.3	-0.101	35.2	-26.1	-50.3
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	64.400	48.000	16.558	2.740	3.140	8.250	8.250	8.250
Nbr of stocks (in thousands)	12,842	15,241	19,075	23,459	34,008	45,020	-	-
Announcement Date	3/1/22	3/14/23	3/14/24	3/11/25	3/16/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AGENUS INC.	12.29x	-	-	-	376M
LONZA GROUP AG	34.87x	6.21x	18.47x	0.92%	51.65B
REVOLUTION MEDICINES, INC.	-21.73x	287.37x	-22.58x	-.--%	45.31B
IQVIA HOLDINGS INC.	33.41x	3.25x	14.01x	-.--%	42.7B
BEONE MEDICINES AG	49.3x	5.73x	31.35x	-.--%	42.79B
CELLTRION, INC.	28.8x	8.7x	21.99x	0.4%	32.87B
MEDPACE HOLDINGS, INC.	34.92x	5.73x	26.03x	-.--%	17.14B
EUROFINS SCIENTIFIC SE	24.7x	2.14x	9.25x	1.09%	15.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	79.62x	4.17x	16.19x	-.--%	14.21B
Average	30.69x	40.41x	14.34x	0.3%	29.12B
Weighted average by Cap.	28.26x	54.27x	13.02x	0.29%